96 related articles for article (PubMed ID: 16761435)
61. Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma.
Liao Z; Zhou L; Wang C; He Z; Wang X; Luo X; Chen S; Yang L; Tan H; Li Y
DNA Cell Biol; 2015 Mar; 34(3):201-7. PubMed ID: 25513989
[TBL] [Abstract][Full Text] [Related]
62. MiRNA-584 suppresses the progression of NK/T-cell lymphoma by targeting FOXO1.
Wang CC; Han L; Hou YH; Ying XY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4404-4411. PubMed ID: 32373978
[TBL] [Abstract][Full Text] [Related]
63. Mature T-cell and NK/T-cell neoplasms.
Pfreundschuh M
Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 8-9. PubMed ID: 16491630
[No Abstract] [Full Text] [Related]
64. RPS13, a potential universal reference gene for normalisation of gene expression in multiple human normal and cancer tissue samples.
Rashid M; Shah SG; Natu A; Verma T; Rauniyar S; Gera PB; Gupta S
Mol Biol Rep; 2021 Dec; 48(12):7967-7974. PubMed ID: 34657252
[TBL] [Abstract][Full Text] [Related]
65. [Relationship between children's NK/T cell lymphoma and Survivin gene expression].
Ming M; Wang DB; Ke ZY; Zou DD; Yi JH; Yao JX; Zhang J
Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):310-1. PubMed ID: 15924735
[No Abstract] [Full Text] [Related]
66. Characteristic gene alterations in primary gastrointestinal T- and NK-cell lymphomas.
Lee G; Ryu HJ; Choi JW; Kang H; Yang WI; Yang IS; Seo MK; Kim S; Yoon SO
Leukemia; 2019 Jul; 33(7):1797-1832. PubMed ID: 30675012
[No Abstract] [Full Text] [Related]
67. [NK-cell tumors].
Oshimi K
Rinsho Ketsueki; 2000 Mar; 41(3):169-72. PubMed ID: 10774242
[No Abstract] [Full Text] [Related]
68. A major turning point in NK/T-cell lymphoma?
Jaccard A; Hermine O
Blood; 2017 Apr; 129(17):2342-2343. PubMed ID: 28450574
[No Abstract] [Full Text] [Related]
69. Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified.
Gazzola A; Bertuzzi C; Agostinelli C; Righi S; Pileri SA; Piccaluga PP
Haematologica; 2009 Jul; 94(7):1036-7. PubMed ID: 19508975
[No Abstract] [Full Text] [Related]
70. Microsatellite instability in natural killer cell-like T-cell lymphomas in immunocompromised and immunocompetent individuals.
Larson RS; Manning S; Macon WR; Vnencak-Jones C
Blood; 1997 Feb; 89(3):1114-5. PubMed ID: 9028347
[No Abstract] [Full Text] [Related]
71. Topics on the molecular pathogenesis and therapeutic approaches for T/NK-cell lymphoma.
Yamaguchi M
J Clin Exp Hematop; 2017; 57(3):85-86. PubMed ID: 29279554
[No Abstract] [Full Text] [Related]
72. Altered gene expression in cerulein-stimulated pancreatic acinar cells: pathologic mechanism of acute pancreatitis.
Yu JH; Lim JW; Kim H
Korean J Physiol Pharmacol; 2009 Dec; 13(6):409-16. PubMed ID: 20054485
[TBL] [Abstract][Full Text] [Related]
73. [Amplification and specific expression of T-bet gene in nasal NK/T cell lymphoma].
Ye YH; Li T; Qi WX; Guo ZQ; Zhang B
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):881-5. PubMed ID: 16759512
[TBL] [Abstract][Full Text] [Related]
74. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Donner LR
Pediatr Dev Pathol; 2008; 11(4):325; author reply 326. PubMed ID: 18839448
[No Abstract] [Full Text] [Related]
75. [Nasal natural killer/T-cell lymphoma genes].
Li JM; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):308-10. PubMed ID: 16181557
[No Abstract] [Full Text] [Related]
76. NK-cell intravascular lymphomatosis--a mini-review.
Nakamichi N; Fukuhara S; Aozasa K; Morii E
Eur J Haematol; 2008 Jul; 81(1):1-7. PubMed ID: 18462254
[TBL] [Abstract][Full Text] [Related]
77. [Real-time fluorescence quantitative PCR in detecting ribosome protein S13 (RPS13) gene expression in NK/T cell lymphoma].
Yang F; Liu WP; He MX; Tang QL; Zhao S; Zhang WY; Xia QJ; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):464-6. PubMed ID: 16761435
[TBL] [Abstract][Full Text] [Related]
78. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
